Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
afatinib (gilotrif) (1 trial)
cetuximab (erbitux) (1 trial)
Colorectal Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)